The US Food and Drug Administration has approved alirocumab (Praluent, Regeneron Pharmaceuticals) injection as add-on therapy for adults with homozygous familial […]
FDA Okays New Indication for Alirocumab in Homozygous FH
The US Food and Drug Administration has approved alirocumab (Praluent, Regeneron Pharmaceuticals) injection as add-on therapy for adults with homozygous familial […]
Lipodystrophy Causes
Lipodystrophy is a fat metabolism error, which manifests clinically in the form of excessive fat deposition in some areas such […]